Cognition Disorders Recruiting Phase 3 Trials for Florbetapir (18F) (DB09149)

IndicationStatusPhase
DBCOND0027877 (Cognition Disorders)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02813434Cerebral Amyloid Imaging Using Florbetapir (AV-45)Diagnostic